Does IXEKIZUMAB Cause Nasopharyngitis? 578 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 578 reports of Nasopharyngitis have been filed in association with IXEKIZUMAB (TALTZ). This represents 1.7% of all adverse event reports for IXEKIZUMAB.
578
Reports of Nasopharyngitis with IXEKIZUMAB
1.7%
of all IXEKIZUMAB reports
1
Deaths
26
Hospitalizations
How Dangerous Is Nasopharyngitis From IXEKIZUMAB?
Of the 578 reports, 1 (0.2%) resulted in death, 26 (4.5%) required hospitalization.
Is Nasopharyngitis Listed in the Official Label?
Yes, Nasopharyngitis is listed as a known adverse reaction in the official FDA drug label for IXEKIZUMAB.
What Other Side Effects Does IXEKIZUMAB Cause?
Injection site pain (3,799)
Psoriasis (2,818)
Drug ineffective (2,759)
Injection site erythema (2,144)
Injection site reaction (1,701)
Injection site swelling (1,615)
Incorrect dose administered (1,032)
Covid-19 (861)
Product dose omission issue (832)
Therapy interrupted (796)
What Other Drugs Cause Nasopharyngitis?
ADALIMUMAB (13,753)
ETANERCEPT (12,421)
METHOTREXATE (8,046)
TOFACITINIB (7,781)
SECUKINUMAB (7,022)
TOCILIZUMAB (6,664)
RITUXIMAB (6,321)
ABATACEPT (6,143)
INFLIXIMAB (5,353)
CERTOLIZUMAB PEGOL (5,295)
Which IXEKIZUMAB Alternatives Have Lower Nasopharyngitis Risk?
IXEKIZUMAB vs JAKAFI
IXEKIZUMAB vs JANUMET
IXEKIZUMAB vs JANUVIA
IXEKIZUMAB vs JETREA
IXEKIZUMAB vs JUXTAPID